| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K16147474 |
| PharmacoGx | BRD-K16147474 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RRBP1 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.07 |
| mRNA | EIF2B3 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | PSMB4 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | CPEB2 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.07 |
| mRNA | POLE4 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | PHF11 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.07 |
| mRNA | TMA16 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.07 |
| mRNA | PER2 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.07 |
| mRNA | HOOK2 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.07 |
| mRNA | COPRS | CTRPv2 | pan-cancer | AAC | -0.079 | 0.07 |
